关键词：免疫球蛋白；抗体；细菌和病毒；结合特定；抗原；预防感染
摘 要：Immunoglobulins, also known as antibodies, are proteins that help neutralize foreign objects such as bacteria and viruses. They help recognize and bind to particular antigens. Based on the difference in the amino acid sequence in the fragment crystallizable (Fc) region of the antibody heavy chain, they can be categorized into the following isotypes: IgA, IgD, IgE, IgG, and IgM. In 1952, immunoglobulin products were used for the first time to treat immune deficiency. They can be administered by either the intravenous (IV) or subcutaneous (SC) route. Immunoglobulin products given intravenously usually contain IgG. Immunoglobulin products are used to treat primar antibody deficiency, complex immune deficiency disorders, and life threatening infections. Immunoglobulin therapeutic products help prevent infections, improving the quality of life and increasing life expectancy.
目 录：

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

Assumptions

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

PART 05: Plasma products: An overview

Components of blood plasma

Manufacturing process of plasma products

Clinical uses of plasma

Cost of plasma therapeutics

PART 06: Regulation of plasma products

PART 07: Pipeline portfolio

Information on few pipeline candidates

PART 08: Market landscape

Market overview

Market size and forecast

Five forces analysis

PART 09: Market segmentation by type of immunoglobulins

PART 10: Market segmentation by application

Immunodeficiency diseases

Hypogammaglobulinemia

CIDP

Congenital AIDS

CLL

Myasthenia gravis

MMN

ITP

Kawasaki disease

Guillain–Barré syndrome

Others

PART 11: Market segmentation by ROA

IVIG products

SCIG products

IMIG products

PART 12: Market segmentation by volume

Market overview

Immunoglobulin products market by volume in

Americas

Immunoglobulin products market by volume in EMEA

Immunoglobulin products market by volume in APAC

PART 13: Geographical segmentation

Immunoglobulin products market in Americas

Immunoglobulin products market in EMEA

Immunoglobulin products market in APAC

PART 14: Market drivers

Growing older population

Increase in individuals with PID

Promising pipeline

Approval of immunoglobulins to treat

neuroimmunological disorders

Rise in demand for IVIG therapies

PART 15: Impact of drivers

PART 16: Market challenges

High cost of therapy

Product recalls by US FDA

Limited plasma fractionation capacity

Post-transfusion adverse reactions

Stringent regulatory guidelines

PART 17: Impact of drivers and challenges

PART 18: Market trends

Patient assistance programs

Strategic alliances and M&A

Increased use of synthetic/recombinant products

Rise in awareness of PID

PART 19: Vendor landscape

Competitive scenario

Market share analysis 2015

CSL

Baxalta

Grifols

Octapharma

Kedrion

Biotest Pharmaceuticals

Other prominent vendors

PART 20: Appendix

List of abbreviations

PART 21: Explore Technavio